US OptionsDetailed Quotes
AMED250117P95000
- 3.80
- -1.30-25.49%
15min DelayClose Jan 3 16:00 ET
3.80High3.80Low
3.80Open5.10Pre Close25 Volume125 Open Interest95.00Strike Price9.50KTurnover34.15%IV0.09%PremiumJan 17, 2025Expiry Date3.72Intrinsic Value100Multiplier12DDays to Expiry0.08Extrinsic Value100Contract SizeAmericanOptions Type-0.7238Delta0.0598Gamma20.06Leverage Ratio-0.0719Theta-0.0192Rho-14.52Eff Leverage0.0557Vega
Amedisys Stock Discussion
Sign in to post a comment
$Amedisys (AMED.US)$ divergency with good fundamental Also gap so it looks good and risk to rewards is acceptable
1
$Inhibikase Therapeutics (IKT.US)$
learn from
$Amedisys (AMED.US)$
$AMC Entertainment (AMC.US)$
$Fulcrum Therapeutics (FULC.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech (PMCB.US)$
learn from
$Amedisys (AMED.US)$
$AMC Entertainment (AMC.US)$
$Fulcrum Therapeutics (FULC.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech (PMCB.US)$
2
No comment yet
Kofi : Do u see it going above 100 ?